Proteomic profiling based classification of CLL provides prognostication for modern therapy and identifies novel therapeutic targets

Authors: Ti’ara L. Griffen, Fieke W. Hoff, Yihua Qiu, James W. Lillard, Alessandra Ferrajoli, Philip Thompson, Endurance Toro, Kevin Ruiz, Jan Burger, William Wierda, Steven M. Kornblau

Source: Blood Cancer Journal, Vol 12, Iss 3, Pp 1-14 (2022)

Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/2044-5385

Access URL: https://doaj.org/article/db77fb9301b64bc0981763c122e79287